Sai Life Sciences delivers advanced discovery, contract development and manufacturing solutions through a broad suite of capabilities across the molecular lifecycle.
Eczacıbaşı Monrol specializes in producing agents for PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scans, which are critical for detecting cancer, cardiological diseases and brain disorders, among other serious diseases.
Ali Raif is one of the oldest Turkish Pharmaceutical companies, and has developed from manufacturing and marketing under license to producing generics and other drugs.
GVK BIO is a global Contract Research & Development Organization providing drug discovery and development services to the biopharma industry and experiencing rapid growth.
DEFI Healthcare is an Ahmedabad-based pharmaceutical company involved in the manufacturing and supply of a wide range of avant-garde pharmaceuticals to semi-regulated and non-regulated markets across the globe.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.